Extended Data Fig. 4: Effect of LPS-5 Phage Therapy on PsA Elastase Production.

Secreted elastase activity (U/mL) from PsA sputum isolates taken pre- and post-therapy from (A) patient 1 (Npre =1, Npost =3, p=NA), (B) patient 2 (Npre =4, Npost =5, p=0.2857), (C) patient 3 (Npre =1, Npost =1, p=NA), (D) patient 4 (Npre =1, Npost =6, p=NA), (E) patient 5 (Npre =2, Npost =4, p=0.3333), (F) patient 6 (Npre =3, Npost =3, p=0.2032), (G) patient 7 (Npre =2, Npost =5, p=0.2381), (H) patient 8 (Npre =3, Npost =1, p=NA), and (I) patient 9 (Npre =1, Npost =3, p=NA). Data representative of two independent experiments; error bars represent median (Mann-Whitney test).